+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Corticosteroids Therapy Market - Global Forecast 2026-2032- Product Image
Corticosteroids Therapy Market - Global Forecast 2026-2032- Product Image
Sale

Corticosteroids Therapy Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888287
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Corticosteroids Therapy Market is projected to reach USD 6.68 Billion in 2026. It is expected to continue growing at a CAGR of 5.31%, reaching USD 9.13 Billion by 2032.

Corticosteroids therapy encompasses medicines used to reduce inflammation and modify immune activity across respiratory, dermatologic, rheumatologic, allergic, gastrointestinal, ophthalmic, and other conditions. Clinical use spans topical, inhaled, oral, injectable, and localized formulations. Decision-making increasingly balances speed of symptom control with risks associated with prolonged exposure, including infection, metabolic effects, bone loss, adrenal suppression, and ocular complications.

Treatment Is Shifting Toward Precision and Safer Use

The therapeutic landscape is moving toward indication-specific treatment, lower effective doses, shorter courses, localized delivery, and structured tapering where appropriate. Clinicians are placing greater emphasis on steroid-sparing strategies, monitoring protocols, patient education, and shared decisions about treatment duration. Advances in inhalation devices, topical formulations, depot delivery, and combination approaches are supporting more targeted administration while stewardship efforts seek to limit avoidable systemic exposure.

Artificial Intelligence Strengthens Corticosteroid Stewardship

Artificial intelligence can support corticosteroid therapy by helping identify patients at risk of adverse effects, flagging potentially inappropriate duration or dosing, and assisting with treatment-response monitoring. It may also improve clinical-trial recruitment, adverse-event surveillance, medical-image interpretation, and prediction of relapse or treatment resistance. Safe adoption requires representative data, transparent validation, clinician oversight, privacy safeguards, and clear accountability because algorithmic outputs should complement rather than replace individualized clinical judgment.

Regional Differences Shape Access, Practice, and Safety

North America generally combines broad diagnostic capacity with strong monitoring expectations, while Latin America faces variation in affordability, supply continuity, and specialist access. Europe emphasizes evidence-based prescribing, pharmacovigilance, and coordinated standards, although access and reimbursement differ across countries. The Middle East reflects wide differences in healthcare infrastructure and specialist availability, and Africa continues to manage uneven access, diagnostic constraints, and the need for resilient primary care. Asia-Pacific contains highly diverse systems, from advanced specialty services to settings where availability, affordability, and continuity of follow-up remain central concerns.

Economic and Alliance Groups Reveal Diverse Priorities

ASEAN markets commonly prioritize affordability, supply reliability, and scalable primary-care delivery. BRICS countries combine substantial clinical capacity with marked differences in regulation, domestic production, and access. The European Union places emphasis on harmonized evidence, safety monitoring, and cross-border standards. G7 health systems generally focus on stewardship, innovation, and management of chronic-treatment risks. GCC countries often benefit from comparatively strong healthcare investment while continuing to address workforce and access variation. NATO members show diverse health-system models but share preparedness, procurement, and continuity-of-care considerations relevant to essential medicines.

Country-Level Priorities Span Innovation, Access, and Stewardship

Australia emphasizes evidence-based prescribing and geographically equitable access. Brazil and Mexico face the combined priorities of affordability, public-sector availability, and consistent quality across large and diverse populations. Canada and the United States have advanced specialty care alongside attention to pricing, monitoring, and disparities in access. China and India are balancing expanding healthcare capacity with quality assurance and broad affordability. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom generally focus on clinical governance, pharmacovigilance, and appropriate long-term use, while their reimbursement pathways and prescribing practices differ. Russia’s priorities include supply resilience, healthcare access across extensive territory, and consistent clinical oversight.

Industry Leaders Should Prioritize Stewardship, Delivery, and Evidence

Leaders should develop products and services that support the lowest effective exposure, practical administration, adherence, and monitoring of cumulative risk. Evidence plans should distinguish outcomes by route, indication, duration, age, comorbidity, and concurrent therapy, while real-world data can help identify safety signals and treatment gaps. Organizations should strengthen supply-chain resilience, transparent quality systems, clinician education, patient instructions, and responsible AI governance. Partnerships with health systems and regulators can improve appropriate use without compromising timely access to essential therapy.

Methodology for a Reliable Corticosteroids Therapy Assessment

This executive summary uses a structured secondary-research framework covering therapeutic applications, routes of administration, safety considerations, clinical practice, access conditions, regulation, and technology adoption. Findings are organized across the specified regions, country groupings, and countries to reflect differences in healthcare infrastructure and policy. Interpretation is limited to qualitative, evidence-oriented insights; no market estimates, market shares, forecasts, or company-level comparisons are included. Conclusions should be validated against current clinical guidelines, regulatory communications, peer-reviewed evidence, and local formularies before operational decisions are made.

The Strategic Imperative Is Effective Control With Lower Cumulative Risk

Corticosteroids therapy remains clinically important because it can provide rapid control of inflammation and immune-mediated disease. Its future direction will depend on disciplined prescribing, safer delivery, stronger monitoring, equitable access, and evidence-led integration of digital tools. Organizations that connect innovation with stewardship and health-system realities will be better positioned to improve outcomes while reducing preventable harms associated with unnecessary or prolonged exposure.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Corticosteroids Therapy Market, by Drug Type
7.1. Introduction
7.2. Budesonide
7.3. Dexamethasone
7.4. Hydrocortisone
7.5. Methylprednisolone
7.6. Prednisone
8. Corticosteroids Therapy Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Nebulizer
8.3. Injectable
8.3.1. Intramuscular
8.3.2. Intravenous
8.3.3. Subcutaneous
8.4. Oral
8.4.1. Suspension
8.4.2. Tablet
8.5. Topical
8.5.1. Cream
8.5.2. Lotion
8.5.3. Ointment
9. Corticosteroids Therapy Market, by Dosage Form
9.1. Introduction
9.2. Cream
9.3. Injection
9.4. Suspension
9.5. Tablet
10. Corticosteroids Therapy Market, by Indication
10.1. Introduction
10.2. Allergic Rhinitis
10.3. Asthma
10.4. Dermatological Disorders
10.5. Inflammatory Bowel Disease
10.6. Rheumatoid Arthritis
11. Corticosteroids Therapy Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Corticosteroids Therapy Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. Corticosteroids Therapy Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. BRICS
13.5. European Union
13.6. ASEAN
13.7. GCC
14. Corticosteroids Therapy Market, by Country
14.1. Introduction
14.2. China
14.3. United States
14.4. Japan
14.5. India
14.6. Germany
14.7. United Kingdom
14.8. Australia
14.9. France
14.10. South Korea
14.11. Italy
14.12. Canada
14.13. Russia
14.14. Brazil
14.15. Mexico
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Allergan PLC
16.3. Amgen Inc.
16.4. AstraZeneca PLC
16.5. Biogen Inc.
16.6. Boehringer Ingelheim GmbH
16.7. Bristol-Myers Squibb Company
16.8. Cipla Inc.
16.9. Dr. Reddy's Laboratories Ltd.
16.10. Eli Lilly and Company
16.11. Galderma Group
16.12. Gilead Sciences, Inc.
16.13. GlaxoSmithKline PLC
16.14. Lupin Pharmaceuticals, Inc.
16.15. Merck & Co., Inc.
16.16. Mylan N.V.
16.17. Novartis AG
16.18. Pfizer Inc.
16.19. Sanofi S.A.
16.20. SANTHERA PHARMACEUTICALS
16.21. Sun Pharmaceutical Industries Ltd.
16.22. Takeda Pharmaceutical Company Limited
16.23. Teva Pharmaceutical Industries Ltd.
17. Key Experts
List of Figures
FIGURE 1. Global Corticosteroids Therapy Market, Years Considered for the Study
FIGURE 2. Global Corticosteroids Therapy Market, Research Design
FIGURE 3. Global Corticosteroids Therapy Market, Research Framework
FIGURE 4. Global Corticosteroids Therapy Market, Data Triangulation
FIGURE 5. Global Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Corticosteroids Therapy Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Corticosteroids Therapy Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Corticosteroids Therapy Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Corticosteroids Therapy Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Corticosteroids Therapy Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Corticosteroids Therapy Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Corticosteroids Therapy Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Corticosteroids Therapy Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Corticosteroids Therapy Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 15. Global Corticosteroids Therapy Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Corticosteroids Therapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Corticosteroids Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Corticosteroids Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Corticosteroids Therapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Corticosteroids Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Corticosteroids Therapy Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Corticosteroids Therapy Market Segmentation & Coverage
TABLE 2. Global Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Budesonide Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Budesonide Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Budesonide Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dexamethasone Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dexamethasone Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dexamethasone Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hydrocortisone Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hydrocortisone Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hydrocortisone Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Methylprednisolone Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Methylprednisolone Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Methylprednisolone Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Prednisone Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Prednisone Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Prednisone Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 20. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Dry Powder Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Dry Powder Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Dry Powder Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Metered Dose Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Metered Dose Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Metered Dose Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Nebulizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Nebulizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Nebulizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Lotion Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Lotion Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Lotion Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Ointment Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Ointment Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Ointment Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 66. Global Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 79. Global Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Dermatological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Dermatological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Dermatological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 95. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 115. Europe Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Europe Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 117. Europe Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 118. Europe Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 119. Europe Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 120. Europe Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 121. Europe Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 122. Europe Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 123. Europe Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 124. Europe Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 125. North America Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 127. North America Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 128. North America Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 129. North America Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 130. North America Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 131. North America Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 132. North America Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 133. North America Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. North America Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 135. Latin America Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Latin America Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 137. Latin America Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 138. Latin America Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 139. Latin America Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 140. Latin America Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 141. Latin America Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 142. Latin America Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 143. Latin America Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 144. Latin America Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 145. Africa Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Africa Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 147. Africa Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 148. Africa Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 149. Africa Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 150. Africa Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 151. Africa Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 152. Africa Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 153. Africa Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 154. Africa Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 155. Middle East Corticosteroids Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Middle East Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 157. Middle East Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. Middle East Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 159. Middle East Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 160. Middle East Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 161. Middle East Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 162. Middle East Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 163. Middle East Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 164. Middle East Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 165. Global Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. NATO Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. NATO Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 168. NATO Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. NATO Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 170. NATO Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 171. NATO Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 172. NATO Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 173. NATO Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 174. NATO Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 175. NATO Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 176. G7 Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. G7 Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 178. G7 Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. G7 Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 180. G7 Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 181. G7 Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 182. G7 Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 183. G7 Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 184. G7 Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. G7 Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 186. BRICS Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. BRICS Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 188. BRICS Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 189. BRICS Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 190. BRICS Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 191. BRICS Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 192. BRICS Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 193. BRICS Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 194. BRICS Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 195. BRICS Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 196. European Union Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. European Union Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 198. European Union Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 199. European Union Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 200. European Union Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 201. European Union Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 202. European Union Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 203. European Union Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 204. European Union Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. European Union Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 206. ASEAN Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. ASEAN Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 208. ASEAN Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. ASEAN Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 210. ASEAN Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 211. ASEAN Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 212. ASEAN Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 213. ASEAN Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 214. ASEAN Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. ASEAN Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 216. GCC Corticosteroids Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. GCC Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 218. GCC Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 219. GCC Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 220. GCC Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 221. GCC Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 222. GCC Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 223. GCC Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 224. GCC Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 225. GCC Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 226. Global Corticosteroids Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. China Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 228. China Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 229. China Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 230. China Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 231. China Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 232. China Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 233. China Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 234. China Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 235. China Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. China Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 237. United States Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 238. United States Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 239. United States Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 240. United States Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 241. United States Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 242. United States Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 243. United States Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 244. United States Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 245. United States Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 246. United States Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 247. Japan Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 248. Japan Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 249. Japan Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 250. Japan Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 251. Japan Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 252. Japan Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 253. Japan Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 254. Japan Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 255. Japan Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 256. Japan Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 257. India Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 258. India Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 259. India Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 260. India Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 261. India Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 262. India Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 263. India Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 264. India Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 265. India Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 266. India Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 267. Germany Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 268. Germany Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 269. Germany Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 270. Germany Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 271. Germany Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 272. Germany Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 273. Germany Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 274. Germany Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 275. Germany Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 276. Germany Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 277. United Kingdom Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 278. United Kingdom Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 279. United Kingdom Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 280. United Kingdom Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 281. United Kingdom Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 282. United Kingdom Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 283. United Kingdom Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 284. United Kingdom Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 285. United Kingdom Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 286. United Kingdom Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 287. Australia Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 288. Australia Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 289. Australia Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 290. Australia Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 291. Australia Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 292. Australia Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 293. Australia Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 294. Australia Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 295. Australia Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 296. Australia Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 297. France Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 298. France Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 299. France Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 300. France Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 301. France Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 302. France Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 303. France Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 304. France Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 305. France Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 306. France Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 307. South Korea Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 308. South Korea Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 309. South Korea Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 310. South Korea Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 311. South Korea Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 312. South Korea Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 313. South Korea Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 314. South Korea Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 315. South Korea Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 316. South Korea Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 317. Italy Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 318. Italy Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 319. Italy Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 320. Italy Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 321. Italy Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 322. Italy Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 323. Italy Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 324. Italy Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 325. Italy Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 326. Italy Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 327. Canada Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 328. Canada Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 329. Canada Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 330. Canada Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 331. Canada Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 332. Canada Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 333. Canada Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 334. Canada Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 335. Canada Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 336. Canada Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 337. Russia Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 338. Russia Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 339. Russia Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 340. Russia Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 341. Russia Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 342. Russia Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 343. Russia Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 344. Russia Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 345. Russia Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 346. Russia Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 347. Brazil Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 348. Brazil Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 349. Brazil Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 350. Brazil Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 351. Brazil Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 352. Brazil Corticosteroids Therapy Market Size, by Oral, 2017-2032 (USD Million)
TABLE 353. Brazil Corticosteroids Therapy Market Size, by Topical, 2017-2032 (USD Million)
TABLE 354. Brazil Corticosteroids Therapy Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 355. Brazil Corticosteroids Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 356. Brazil Corticosteroids Therapy Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 357. Mexico Corticosteroids Therapy Market Size, 2017-2032 (USD Million)
TABLE 358. Mexico Corticosteroids Therapy Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 359. Mexico Corticosteroids Therapy Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 360. Mexico Corticosteroids Therapy Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 361. Mexico Corticosteroids Therapy Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 362. Mexico Corticosteroids Th

Companies Mentioned

  • Abbott Laboratories
  • Allergan PLC
  • Amgen Inc.
  • AstraZeneca PLC
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Galderma Group
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SANTHERA PHARMACEUTICALS
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.68 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.13 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Adrenal Corticosteroid Inhibitors Market - Global Forecast 2026-2032 - Product Image

Adrenal Corticosteroid Inhibitors Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Corticosteroids Inhalation Formulation Market - Global Forecast 2026-2032 - Product Image

Corticosteroids Inhalation Formulation Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Corticosteroids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Corticosteroids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From

About the Corticosteroid Market

The Corticosteroid market is a segment of the Healthcare Services industry that focuses on the production and distribution of corticosteroid drugs. Corticosteroids are a class of drugs used to treat a variety of conditions, including allergies, asthma, and autoimmune diseases. They are also used to reduce inflammation and swelling. Corticosteroids are available in both oral and injectable forms, and are often prescribed in combination with other medications. The Corticosteroid market is highly competitive, with a number of large pharmaceutical companies producing and distributing these drugs. Companies in the market are focused on developing new formulations and delivery systems to improve patient outcomes. They are also investing in research and development to create new treatments for a variety of conditions. Some of the major companies in the Corticosteroid market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the production, distribution, and marketing of corticosteroid drugs. They are also involved in research and development to create new treatments and formulations. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.